Scale-up and quality control challenges in the industrial manufacturing of nanoformulations: Current trends and future perspectives

Abstract

Nanoformulations have rapidly transformed pharmaceutical research and industrial drug delivery, offering solutions for enhanced solubility, targeted therapy, and improved pharmacokinetics. However, translating these innovations from laboratory scale to industrial manufacturing presents significant challenges, particularly in process scale-up and quality control. This review critically examines current trends in the industrial production of nanoformulations, including nanoparticles, liposomes, and nanoemulsions, with an emphasis on scalable manufacturing technologies and the maintenance of critical quality attributes. Key obstacles such as reproducibility, batch-to-batch consistency, equipment limitations, and regulatory compliance are discussed, alongside advances in analytical techniques for quality assurance. Case studies of successful industrial-scale nanoformulation products are presented to illustrate practical solutions and ongoing hurdles. Finally, the review explores future perspectives, including the integration of automation, artificial intelligence, and sustainable manufacturing practices, which are poised to address existing limitations and shape the next generation of nanomedicine production. This synthesis aims to guide researchers and industry professionals in overcoming the bottlenecks associated with large-scale nanoformulation manufacturing and ensuring the delivery of safe, effective, and high-quality nanopharmaceuticals.